Loading stock data…
Loading stock data…
US$26.88
Get one email when PLSE crosses your level. Checked every 15 minutes during market hours.
▲ +0.56 (2.13%)up today
Could not load chart data. Please try again shortly.
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
52.1
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
0.30
Bearish momentumMACD below its signal line (0.62).
50-day average
25.39
Price aboveShort-term trend reference.
200-day average
19.61
Price aboveLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Medical Instruments & Supplies
Pulse Biosciences, Inc. is a bioelectric medicine company specializing in the development of novel Nanosecond Pulsed Field Ablation (nsPFA) platforms. Its primary focus centers on the patented nPulse technology, which enables precise, non-thermal ablation of soft tissues for applications in dermatology, cardiology, and surgical procedures. Key products include the CellFX System for treating benign skin lesions, the CellFX nsPFA Percutaneous Electrode for soft tissue ablation, the CellFX nsPFA Ca…
www.pulsebiosciences.com3 strong buy · 5 buy · 1 hold · 0 sell · 0 strong sell (9 analysts, 2026-07-01)
3 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (8 analysts, 2026-06-01)
3 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (8 analysts, 2026-05-01)
3 strong buy · 4 buy · 1 hold · 0 sell · 0 strong sell (8 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-04 | -0.22 | -0.24 | ✗ Miss |
| 2026-02-19 | -0.21 | -0.18 | ✓ Beat |
| 2025-11-05 | -0.31 | -0.29 | ✓ Beat |
| 2025-08-12 | -0.26 | -0.28 | ✗ Miss |
| 2024-05-07 | -0.24 | -0.18 | ✓ Beat |
| 2023-08-09 | -0.22 | -0.22 | ✓ Beat |
| 2023-05-11 | -0.22 | -0.26 | ✗ Miss |
Companies in the same industry, via Finnhub